237 related articles for article (PubMed ID: 21437908)
21. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.
Parveen F; Bender D; Law SH; Mishra VK; Chen CC; Ke LY
Cells; 2019 Dec; 8(12):. PubMed ID: 31817238
[TBL] [Abstract][Full Text] [Related]
22. Effect of exercise duration on ceramide metabolism in the rat heart.
Baranowski M; Zabielski P; Blachnio A; Gorski J
Acta Physiol (Oxf); 2008 Apr; 192(4):519-29. PubMed ID: 17970831
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
25. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
26. Sphingomyelin metabolism is developmentally regulated in rat lung.
Longo CA; Tyler D; Mallampalli RK
Am J Respir Cell Mol Biol; 1997 May; 16(5):605-12. PubMed ID: 9160843
[TBL] [Abstract][Full Text] [Related]
27. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
28. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
30. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
[TBL] [Abstract][Full Text] [Related]
31. Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat.
Górska M; Dobrzyń A; Zendzian-Piotrowska M; Górski J
Horm Metab Res; 2004 Jan; 36(1):14-21. PubMed ID: 14983401
[TBL] [Abstract][Full Text] [Related]
32. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status.
Fisher FM; McTernan PG; Valsamakis G; Chetty R; Harte AL; Anwar AJ; Starcynski J; Crocker J; Barnett AH; McTernan CL; Kumar S
Horm Metab Res; 2002; 34(11-12):650-4. PubMed ID: 12660876
[TBL] [Abstract][Full Text] [Related]
33. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
[TBL] [Abstract][Full Text] [Related]
34. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
Int J Obes (Lond); 2007 Dec; 31(12):1843-8. PubMed ID: 17607322
[TBL] [Abstract][Full Text] [Related]
35. Changes in the metabolism of sphingolipids after subarachnoid hemorrhage.
Testai FD; Xu HL; Kilkus J; Suryadevara V; Gorshkova I; Berdyshev E; Pelligrino DA; Dawson G
J Neurosci Res; 2015 May; 93(5):796-805. PubMed ID: 25597763
[TBL] [Abstract][Full Text] [Related]
36. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
37. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
[TBL] [Abstract][Full Text] [Related]
38. [Expression and regulation of retinol binding protein 4 mRNA in human adipose tissue in obese and type 2 diabetics].
Liu XH; Wei L; Wang LY; Zhu CY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1251-4. PubMed ID: 20646597
[TBL] [Abstract][Full Text] [Related]
39. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes.
Morínigo R; Musri M; Vidal J; Casamitjana R; Delgado S; Lacy AM; Ayuso C; Gomis R; Corominola H
Obes Surg; 2006 Jun; 16(6):745-51. PubMed ID: 16756736
[TBL] [Abstract][Full Text] [Related]
40. Bezafibrate decreases growth stimulatory action of the sphingomyelin signaling pathway in regenerating rat liver.
Zabielski P; Baranowski M; Zendzian-Piotrowska M; Błachnio-Zabielska A; Górski J
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):17-25. PubMed ID: 18024222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
